コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion condition (major depressive disorder and dysthymia).
2 dependence) to 1.032 (between drug abuse and dysthymia).
3 tion for 10-week's duration in patients with dysthymia.
4 k a variety of forms and were not limited to dysthymia.
5 y ill older adults with minor depression and dysthymia.
6 -9) and met criteria for major depression or dysthymia.
7 for major depressive episodes combined with dysthymia.
8 imary care patients with minor depression or dysthymia.
9 tion of periods of euthymia in patients with dysthymia.
10 patients with substance-related disorder and dysthymia.
11 R criteria for major depressive episodes and dysthymia.
12 n mood symptoms and psychosocial outcomes in dysthymia.
13 n the relatives of probands with noncomorbid dysthymia.
14 ide and imipramine hydrochloride in treating dysthymia.
15 %) reported a history of major depression or dysthymia, 15 (42%) a history of phobic disorder, and 23
20 f whom 39 had substance-related disorder and dysthymia and 308 had substance-related disorder only (t
21 roups consisted of subjects with early-onset dysthymia and a co-occurring cluster B personality disor
22 e documented significant comorbidity between dysthymia and axis II personality disorders, particularl
23 f results is consistent with the notion that dysthymia and cluster B personality disorders co-occur b
24 ne of five models of the comorbidity between dysthymia and cluster B personality disorders that was s
26 tients with comorbid major depression and/or dysthymia and diabetes mellitus, but improved depression
27 re was evidence of a shared etiology between dysthymia and heavy smoking, whereas major and double de
30 tal health function in elderly patients with dysthymia and more severely impaired elderly patients wi
31 sive disorders (major depressive episode and dysthymia) and anxiety disorders (generalized anxiety di
32 depressive personality disorder did not have dysthymia, and 60% did not have current major depression
33 or depressive disorder, depressive syndrome, dysthymia, and a comorbid depression condition (major de
34 shold depressive symptoms, minor depression/ dysthymia, and MDD represent a continuum of depressive s
38 on, family conflict, and absence of comorbid dysthymia, anxiety, and drug/alcohol use and impairment
40 Patients with substance-related disorder and dysthymia are referred to (or seek) substance-related di
41 with comorbid substance-related disorder and dysthymia, as compared to patients with substance-relate
43 f mood disorders (major depressive disorder, dysthymia, bipolar disorder), anxiety disorders (panic d
44 arious subtypes of mood disorders, including dysthymia, chronic depression, and atypical depression.
45 e subjects (14 women, 11 men) with DSM-III-R dysthymia, chronic major depression, or double depressio
46 Although depressive personality disorder and dysthymia co-occurred in some subjects, 63% of subjects
47 for lifetime diagnoses of major depression, dysthymia, conduct disorder, drug abuse, and cigarette s
48 M-IV criteria for major depressive disorder, dysthymia, depression disorder not otherwise specified,
49 ents with a diagnosis of early-onset primary dysthymia (DSM-III-R) of at least 5 years' duration with
50 ion, the relatives of probands with comorbid dysthymia exhibited higher rates of cluster B personalit
51 month rates of major depressive episodes and dysthymia for Chinese Americans who reside in Los Angele
52 for psychiatric disorders (major depression, dysthymia, generalized anxiety disorders, and panic atta
53 Patients with substance-related disorder and dysthymia had received more substance-related disorder t
54 nd those with DSM-IV major depression and/or dysthymia have higher medical costs than those without d
55 ting DSM-IV criteria for major depression or dysthymia (hazard ratio, 4.32) and for attempting suicid
56 7; 95% confidence interval [CI], 1.46-2.31), dysthymia (HR, 1.79; 95% CI, 1.11-2.87), and alcohol abu
58 des considerable relief from the symptoms of dysthymia in patients suffering from this chronic affect
59 y MAOA genotype buffered against symptoms of dysthymia in physically abused and multiply-maltreated w
60 harmacotherapy is an effective treatment for dysthymia in terms of psychosocial functioning as well a
63 ellitus and comorbid major depression and/or dysthymia.Intervention Patients were randomly assigned t
68 y MAOA genotype buffered against symptoms of dysthymia, major depressive disorder, and alcohol abuse
69 fective disorders (major depressive episode, dysthymia, manic episode), anxiety (panic, separation an
71 71 years) with minor depression (n = 204) or dysthymia (n = 211) and a Hamilton Depression Rating Sca
72 met DSM-III-R diagnostic criteria for "pure" dysthymia (n = 51), dysthymia with current major depress
73 (n = 515; adjusted OR: .8; 95% CI: .6-1.2), dysthymia (n = 548; adjusted OR: 1.1; 95% CI: .7-1.8), o
74 der (odds ratio=1.72, 95% CI=1.04-2.87), and dysthymia (odds ratio=1.81, 95% CI=1.06-3.12) at 20-year
75 ropositive patients with major depression or dysthymia or both, whether severity of immunosuppression
76 o fulfilled criteria for a diagnosis of pure dysthymia or double depression on entry to the study.
77 r (odds ratio [OR], 1.3; 95% CI, 1.09-1.64), dysthymia (OR, 1.5; 95% CI, 1.09-2.02), bipolar I (OR, 1
78 Although previous studies have shown that dysthymia, or chronic depression, commonly responds to a
79 M-IV criteria for major depressive disorder, dysthymia, or substance-induced mood disorder lasting at
80 cluded 1,356 patients with major depression, dysthymia, or subthreshold depression from 46 managed pr
81 and receiving a diagnosis (major depression/dysthymia: OR, 2.65; 95% CI, 2.20-3.20 and unspecified d
87 th increased risk of current panic disorder, dysthymia, social phobia, major depression, and generali
88 s of cluster B personality disorders without dysthymia than the relatives of probands with noncomorbi
89 and cluster B personality disorders without dysthymia than the relatives of the never ill probands.
92 Patients with substance-related disorder and dysthymia used 4.7 times more substance-related disorder
94 lifetime and 12-month depressive episode and dysthymia was social stress, measured by past traumatic
96 with DSM-IV major depressive disorder and/or dysthymia were compared to 93 individuals with rheumatoi
97 ive patients with subsyndromal depression or dysthymia were randomly assigned to receive either DHEA
99 study, 410 patients with early-onset primary dysthymia were treated in a randomized prospective fashi
100 sion (i.e., major depression superimposed on dysthymia) were randomly assigned to 12 weeks of double-
101 t consideration because of the chronicity of dysthymia, which may require prolonged treatment with an
103 patients with recurrent major depression or dysthymia who had largely recovered after 8 weeks of ant
104 major depression (with or without concurrent dysthymia), who failed to respond to 12 weeks of double-
105 dysthymic probands exhibited higher rates of dysthymia with a cluster B personality disorder, dysthym
107 = 548; adjusted OR: 1.1; 95% CI: .7-1.8), or dysthymia with comorbid major depression (n = 242, adjus
108 stic criteria for "pure" dysthymia (n = 51), dysthymia with current major depression ("double depress
109 disorder (N = 28), subjects with early-onset dysthymia without a cluster B personality disorder (N =
110 hymia with a cluster B personality disorder, dysthymia without a cluster B personality disorder, and
111 hymia with a cluster B personality disorder, dysthymia without a cluster B personality disorder, and
112 with DSM-III-R-defined, early-onset, primary dysthymia without concurrent major depression were rando
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。